ClinicalTrials.Veeva

Menu

Effectiveness of Vagus Nerve Stimulation in Individuals With Tension-Type Headache

B

Bitlis Eren University

Status

Completed

Conditions

Tension-Type Headache

Treatments

Other: Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS)

Study type

Interventional

Funder types

Other

Identifiers

NCT06604637
TTH-VNS

Details and patient eligibility

About

It is planned to examine the effect of Vagus Nerve Stimulation on headache symptoms in individuals with tension-type headache.

Full description

Tension-type headache is the most common primary headache, usually bilateral, characterized by oppressive and squeezing pain of mild or moderate intensity, unchanged by physical activity. It affects approximately 80% of the population and has a point prevalence of 42% in the general population.

There are various pharmacological and non-pharmacological treatment methods for tension-type headache. One of the non-pharmacological treatment methods may be Vagus Nerve Stimulation (VNS). VNS can affect healing processes by regulating the autonomic nervous system and reduce symptoms in tension-type headache.

Enrollment

30 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with tension-type headache according to the International Classification of Headache Disorders (ICHD-3) criteria,
  • Individuals between the ages of 18-65,

Exclusion criteria

  • History of trauma or surgery to the head and neck region,
  • Presence of lesions or metal implants in the application area,
  • Uncontrolled hypertension/abnormal ECG results/history of myocardial infarction/pacemaker and similar cardiovascular disease history/suspicion,
  • Pregnancy or suspicion,
  • Other primary and secondary headache types,
  • Individuals who received physiotherapy in the last 6 months,

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

VNS Group
Experimental group
Description:
In addition to standard treatment, noninvasive transcutaneous auricular vagus nerve stimulation (taVNS) will be applied to this group.
Treatment:
Other: Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS)
Control roup
No Intervention group
Description:
The control group will receive standard treatment ( patient education+lifestyle recommendations).

Trial contacts and locations

1

Loading...

Central trial contact

Mesut Arslan, Assistant Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems